JP2023529844A - エピゲノム編集のための組成物及び方法 - Google Patents

エピゲノム編集のための組成物及び方法 Download PDF

Info

Publication number
JP2023529844A
JP2023529844A JP2022574471A JP2022574471A JP2023529844A JP 2023529844 A JP2023529844 A JP 2023529844A JP 2022574471 A JP2022574471 A JP 2022574471A JP 2022574471 A JP2022574471 A JP 2022574471A JP 2023529844 A JP2023529844 A JP 2023529844A
Authority
JP
Japan
Prior art keywords
seq
fusion protein
aspects
amino acid
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022574471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023529844A5 (cg-RX-API-DMAC10.html
Inventor
ギルバート,ルーク
ワイスマン,ジョナサン
ヌニェス,ジェームズ
ポミエ,グレッグ
Original Assignee
ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア filed Critical ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア
Publication of JP2023529844A publication Critical patent/JP2023529844A/ja
Publication of JP2023529844A5 publication Critical patent/JP2023529844A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/11—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (1.14.11)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/85—Fusion polypeptide containing an RNA binding domain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
JP2022574471A 2020-06-05 2021-06-04 エピゲノム編集のための組成物及び方法 Pending JP2023529844A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063035431P 2020-06-05 2020-06-05
US63/035,431 2020-06-05
US202063118832P 2020-11-27 2020-11-27
US63/118,832 2020-11-27
PCT/US2021/035937 WO2021248023A2 (en) 2020-06-05 2021-06-04 Compositions and methods for epigenome editing

Publications (2)

Publication Number Publication Date
JP2023529844A true JP2023529844A (ja) 2023-07-12
JP2023529844A5 JP2023529844A5 (cg-RX-API-DMAC10.html) 2024-06-11

Family

ID=78831718

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022574471A Pending JP2023529844A (ja) 2020-06-05 2021-06-04 エピゲノム編集のための組成物及び方法

Country Status (12)

Country Link
US (1) US20230212323A1 (cg-RX-API-DMAC10.html)
EP (1) EP4162054A4 (cg-RX-API-DMAC10.html)
JP (1) JP2023529844A (cg-RX-API-DMAC10.html)
KR (1) KR20230021081A (cg-RX-API-DMAC10.html)
CN (1) CN116057180A (cg-RX-API-DMAC10.html)
AU (1) AU2021282659A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022024747A2 (cg-RX-API-DMAC10.html)
CA (1) CA3184882A1 (cg-RX-API-DMAC10.html)
GB (1) GB2612466B (cg-RX-API-DMAC10.html)
IL (1) IL298605A (cg-RX-API-DMAC10.html)
MX (1) MX2022015284A (cg-RX-API-DMAC10.html)
WO (1) WO2021248023A2 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113846019B (zh) * 2021-03-05 2023-08-01 海南师范大学 一种海洋微拟球藻靶向表观基因组遗传调控方法
EP4522735A1 (en) * 2022-05-13 2025-03-19 Integra Therapeutics Use of transposases for improving transgene expression and nuclear localization
JP2026506083A (ja) 2023-02-17 2026-02-20 ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ エピジェネティック修飾を行うための組成物および方法
WO2024238682A2 (en) * 2023-05-15 2024-11-21 The Regents Of The University Of California Cask gene editing system

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016512264A (ja) * 2013-03-15 2016-04-25 ザ ジェネラル ホスピタル コーポレイション 特定のゲノム遺伝子座へのゲノムおよびエピゲノム調節タンパク質のrna誘導型標的化
US20190100732A1 (en) * 2016-06-02 2019-04-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Assay for the removal of methyl-cytosine residues from dna
JP2019528718A (ja) * 2016-09-13 2019-10-17 ザ ジャクソン ラボラトリーThe Jackson Laboratory 標的にされた増大するdna脱メチル化
WO2019204766A1 (en) * 2018-04-19 2019-10-24 The Regents Of The University Of California Compositions and methods for gene editing
US20190352654A1 (en) * 2017-01-26 2019-11-21 The Regents Of The University Of California Targeted gene demethylation in plants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010037001A2 (en) * 2008-09-26 2010-04-01 Immune Disease Institute, Inc. Selective oxidation of 5-methylcytosine by tet-family proteins
DK3178835T3 (da) * 2009-02-03 2019-06-24 Amunix Pharmaceuticals Inc Forlængede rekombinante polypeptider og sammensætninger omfattende samme
AU2015298571B2 (en) * 2014-07-30 2020-09-03 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016512264A (ja) * 2013-03-15 2016-04-25 ザ ジェネラル ホスピタル コーポレイション 特定のゲノム遺伝子座へのゲノムおよびエピゲノム調節タンパク質のrna誘導型標的化
US20190100732A1 (en) * 2016-06-02 2019-04-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Assay for the removal of methyl-cytosine residues from dna
JP2019528718A (ja) * 2016-09-13 2019-10-17 ザ ジャクソン ラボラトリーThe Jackson Laboratory 標的にされた増大するdna脱メチル化
US20190352654A1 (en) * 2017-01-26 2019-11-21 The Regents Of The University Of California Targeted gene demethylation in plants
WO2019204766A1 (en) * 2018-04-19 2019-10-24 The Regents Of The University Of California Compositions and methods for gene editing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CELL, vol. 167, JPN6025033502, 2016, pages 233 - 247, ISSN: 0005855330 *

Also Published As

Publication number Publication date
WO2021248023A2 (en) 2021-12-09
AU2021282659A1 (en) 2023-01-05
GB2612466B (en) 2026-04-01
EP4162054A4 (en) 2025-01-22
EP4162054A2 (en) 2023-04-12
GB202219608D0 (en) 2023-02-08
US20230212323A1 (en) 2023-07-06
BR112022024747A2 (pt) 2023-03-07
WO2021248023A3 (en) 2022-01-27
CN116057180A (zh) 2023-05-02
MX2022015284A (es) 2023-01-19
GB2612466A (en) 2023-05-03
IL298605A (en) 2023-01-01
KR20230021081A (ko) 2023-02-13
CA3184882A1 (en) 2021-12-09

Similar Documents

Publication Publication Date Title
US20240309345A1 (en) Compositions and methods for gene editing
US20230124253A1 (en) Compositions and Methods for Gene Editing
US20230212323A1 (en) Compositions and methods for epigenome editing
KR102405549B1 (ko) Rna-안내 게놈 편집을 위해 특이성을 증가시키기 위한 절단된 안내 rna(tru-grnas)의 이용
JP2025161809A (ja) 新規crispr dnaターゲティング酵素及びシステム
US20180230450A1 (en) Cas9 Genome Editing and Transcriptional Regulation
EP3997217A1 (en) Methods and compositions for scalable pooled rna screens with single cell chromatin accessibility profiling
KR20180043369A (ko) 뉴클레아제 dsb의 완전한 호출 및 시퀀싱(find-seq)
CN114269912A (zh) 新型crispr dna靶向酶及系统
EP3365461B1 (en) Endonuclease-barcoding
CN114144519A (zh) 单碱基置换蛋白以及包含其的组合物
JP2024522764A (ja) 遺伝子編集のため、並びにプログラム可能な遺伝子活性化及び阻害のための微小crisprヌクレアーゼを含むシステム、方法及び組成物
CN116724058A (zh) 用于基因编辑的组合物和方法
EA050506B1 (ru) Композиции для редактирования эпигенома и способы на их основе
JP7402453B2 (ja) 細胞を単離又は同定する方法及び細胞集団
RU2804665C2 (ru) Композиции и способы редактирования генов

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240603

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240603

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250819

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260219

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260512